Amerisourcebergen Revenue 2024

The Amerisourcebergen Revenue history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)
2028e	349.93	2,38
2027e	333.35	2,50
2026e	318.56	2,62
2025e	289.4	2,88
2024e	275.03	3,03
2023e	260.75	3,20
2022	238.59	3,49
2021	213.99	3,17
2020	189.89	2,73
2019	179.59	2,78
2018	167.94	2,77
2017	153.14	2,97
2016	146.85	2,82
2015	135.96	2,55
2014	119.57	2,47
2013	87.96	2,88
2012	78.08	3,39
2011	78.7	3,13
2010	77.78	2,99
2009	71.76	2,93
2008	70.19	2,92
2007	65.67	3,38
2006	60.81	3,49
2005	54.58	3,63
2004	53.12	4,08
2003	49.58	4,49

Amerisourcebergen Aktienanalyse

What does Amerisourcebergen do?

AmerisourceBergen Corp is a global healthcare company that offers a variety of products and services to its customers. It was founded in 2001 through the merger of AmeriSource Health Corp and Bergen Brunswig Corp. The company's business model is based on providing products, services, and technologies for various areas of the healthcare industry, including pharmacy, biotechnology, healthcare services, and retail. AmerisourceBergen Corp has three main business segments: Pharmaceutical Distribution Services, Provider Services, and Pharmaceutical Manufacturer Services. The pharmaceutical distribution service provides fast and reliable delivery of drugs and medical devices to pharmacies, wholesalers, and healthcare facilities. The provider service helps patients get the right medications and offers clinical services to medical facilities. The pharmaceutical manufacturer distribution provides support to its customers in the manufacturing, quality control, and marketing of drugs. The company also offers technology solutions that enable more patient-centered care and improve communication between doctors and patients. AmerisourceBergen Corp has extensive experience and expertise in the industry. It operates a wide network of branches and logistics centers worldwide to ensure its customers always receive the products and services they need. The company offers a wide range of pharmaceutical products, specialized disease drugs, biosimilars, vaccines, and medical devices. It also provides services such as consulting on drug manufacturing and approval, as well as logistics, financial, marketing, and information technology services for its customers. Over the years, AmerisourceBergen Corp has received numerous awards for its outstanding performance in the healthcare industry. The company is known for its commitment to patient-centered care and its innovative solutions to healthcare supply chain issues. With a strong reputation for quality and customer satisfaction, AmerisourceBergen Corp remains one of the leading companies in the healthcare industry. Amerisourcebergen ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Amerisourcebergen's Sales Figures

The sales figures of Amerisourcebergen originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Amerisourcebergen’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Amerisourcebergen's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Amerisourcebergen’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Amerisourcebergen Stock

How much revenue did Amerisourcebergen generate this year?

Amerisourcebergen has achieved a revenue of 275.03 B USD this year.

How much was the turnover of the company Amerisourcebergen compared to the previous year?

The revenue of Amerisourcebergen has increased by 5.48% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Amerisourcebergen?

The revenue of Amerisourcebergen is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Amerisourcebergen measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Amerisourcebergen so important for investors?

The revenue of Amerisourcebergen is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Amerisourcebergen pay?

Over the past 12 months, Amerisourcebergen paid a dividend of 1.87 USD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Amerisourcebergen is expected to pay a dividend of 1.94 USD.

What is the dividend yield of Amerisourcebergen?

The current dividend yield of Amerisourcebergen is 1.01 %.

When does Amerisourcebergen pay dividends?

Amerisourcebergen pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Amerisourcebergen?

Amerisourcebergen paid dividends every year for the past 26 years.

What is the dividend of Amerisourcebergen?

For the upcoming 12 months, dividends amounting to 1.94 USD are expected. This corresponds to a dividend yield of 1.05 %.

In which sector is Amerisourcebergen located?

Amerisourcebergen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amerisourcebergen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amerisourcebergen from 8/28/2023 amounting to 0.485 USD, you needed to have the stock in your portfolio before the ex-date on 8/10/2023.

When did Amerisourcebergen pay the last dividend?

The last dividend was paid out on 8/28/2023.

What was the dividend of Amerisourcebergen in the year 2023?

In the year 2023, Amerisourcebergen distributed 1.865 USD as dividends.

In which currency does Amerisourcebergen pay out the dividend?

The dividends of Amerisourcebergen are distributed in USD.